1. Birg, F, Courcoul, M, Rosnet, O, Bardin, F, Pebusque, MJ, Marchetto, S, Tabilio, A, Mannoni, P & Birnbaum, D. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood, (1992). 80, 2584–2593.
2. Carow, CE, Levenstein, M, Kaufmann, SH, Chen, J, Amin, S, Rockwell, P, Witte, L, Borowitz, MJ, Civin, CI & Small, D. Expression of the hematopoietic growth factor receptor FLT3 (STK-1/FLK2) in human leukemias. Blood, (1996). 87, 1089–1096.
3. Rosnet, O, Bühring, HJ, Marchetto, S, Rappold, I, Lavagna, C, Sainty, D, Arnoulet, C, Chabannon, C, Kanz, L, Hannum, C & Birnbaum, D Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia, (1996). 10, 238–248.
4. Meierhoff, G, Dehmel, U, Gruss, HJ, Rosnet, O, Birnbaum, D, Quentmeier, H, Dirks, W & Drexler, HG Expression of FLT3 receptor and FLT3-ligand in human leukemia–lymphoma cell lines. Leukemia, (1995). 9, 1368–1372.
5. Dehmel, U, Zaborski, M, Meierhoff, G, Rosnet, O, Birnbaum, D, Ludwig, WD, Quentmeier, H & Drexler, HG Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia, (1996). 10, 261–270.